North Macedonia-Skopje: Medical equipments, pharmaceuticals and personal care products

2019/S 133-328428

Contract notice

Supplies
Legal Basis:

Directive 2014/24/EU

Section I: Contracting authority
I.1)Name and addresses
Ministry of Health of Republic of North Macedonia
50 divizija No 6
Skopje
1000
The former Yugoslav Republic of Macedonia
E-mail: tanja.pehcevska@zdravstvo.gov.mk
NUTS code: MK

Internet address(es):

Main address: www.moh.gov.mk
I.2)Information about joint procurement
I.3)Communication
The procurement documents are available for unrestricted and full direct access, free of charge, at: http://www.bjn.gov.mk/
Additional information can be obtained from the abovementioned address
Tenders or requests to participate must be submitted electronically via: http://www.bjn.gov.mk/
I.4)Type of the contracting authority
Ministry or any other national or federal authority, including their regional or local subdivisions
I.5)Main activity
Health

Section II: Object
II.1)Scope of the procurement
II.1.1)Title:

Specific Hematology Therapy for PHI UC for Hematology Skopje for a Period of 1 Year

II.1.2)Main CPV code
33000000
II.1.3)Type of contract
Supplies
II.1.4)Short description:

Specific hematology therapy for PHI UC for hematology Skopje for a period of 1 year.

II.1.5)Estimated total value
II.1.6)Information about lots
This contract is divided into lots: yes
Tenders may be submitted for all lots
II.2)Description
II.2.1)Title:

Specific hematology therapy for PHI UC for hematology Skopje for a period of one year

Lot No: 1 - Lot No: 81

II.2.2)Additional CPV code(s)
33000000
II.2.3)Place of performance
NUTS code: MK
II.2.4)Description of the procurement:

Specific hematology therapy for PHI UC for hematology Skopje for a period of one year

II.2.5)Award criteria
Criteria below
Price
II.2.6)Estimated value
II.2.7)Duration of the contract, framework agreement or dynamic purchasing system
Duration in months: 12
This contract is subject to renewal: no
II.2.10)Information about variants
Variants will be accepted: no
II.2.11)Information about options
Options: no
II.2.12)Information about electronic catalogues
II.2.13)Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds: no
II.2.14)Additional information

Section III: Legal, economic, financial and technical information
III.1)Conditions for participation
III.1.1)Suitability to pursue the professional activity, including requirements relating to enrolment on professional or trade registers
List and brief description of conditions:

Confirmation issued from authorized body for compliance of special criteria for performing legal business activity related to the public procurement subject. A decision issued by the Agency for drugs and medical aids of RM, approving whole sale trading with drugs.

III.1.2)Economic and financial standing
III.1.3)Technical and professional ability
List and brief description of selection criteria:

List of employees responsible for the procurement phase, enclosing M1/M2 formulary for:

— declare a statement for engaged 24 hours available person for monitoring of the cold chain functioning and signalization in case of variations in the temperature range,

— declare a statement for full time employee with university degree in medicine or pharmacy in charge for pharmacovigilance and detection of problems in the drugs quality or errors in the drug’s series, submitting his/her data: name, surname, profession and contact phone in order to be available at any time,

— graduated pharmacist licensed to work in the procurement phases (reception, keeping and issuing drugs),

— submit notice for the parts of the procurement contract which the economic operator intends to transfer to subcontractor.

Minimum level(s) of standards possibly required:

— declare a statement that the conditions for drugs safe keeping, accommodation, transport and managing are fulfilled pursuant to the Guidance for the conditions related to the space, equipment and human resources for awarding approval for whole sale trade with drugs (Off. Gazette of RM No 151/08),

— declare a statement that at the moment of reception of the drugs, the expiry date shall be at least 12 months valid out of the total drugs expiry date,

— if the drug does not have trade approval in RM, then approval for trading in EU members, Norway, Switzerland, USA, Canada and Japan,

— Pharmaceutical Quality Assurance Certificate issued by the manufacturer not older then 3 years or CPP certificate issued by the manufacturer not older then 3 years,

— decision for trading with medicines in Macedonia or temporary approval for parallel import or final approval for parallel import pursuant to the Law on drugs and medical aids in RM.

III.1.5)Information about reserved contracts
III.2)Conditions related to the contract
III.2.2)Contract performance conditions:
III.2.3)Information about staff responsible for the performance of the contract

Section IV: Procedure
IV.1)Description
IV.1.1)Type of procedure
Open procedure
IV.1.3)Information about a framework agreement or a dynamic purchasing system
IV.1.4)Information about reduction of the number of solutions or tenders during negotiation or dialogue
IV.1.6)Information about electronic auction
IV.1.8)Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: no
IV.2)Administrative information
IV.2.1)Previous publication concerning this procedure
IV.2.2)Time limit for receipt of tenders or requests to participate
Date: 08/08/2019
Local time: 13:00
IV.2.3)Estimated date of dispatch of invitations to tender or to participate to selected candidates
IV.2.4)Languages in which tenders or requests to participate may be submitted:
Macedonian
IV.2.6)Minimum time frame during which the tenderer must maintain the tender
IV.2.7)Conditions for opening of tenders
Date: 08/08/2019
Local time: 13:00

Section VI: Complementary information
VI.1)Information about recurrence
This is a recurrent procurement: no
VI.2)Information about electronic workflows
VI.3)Additional information:
VI.4)Procedures for review
VI.4.1)Review body
State Appeals Commission
Skopje
The former Yugoslav Republic of Macedonia
VI.4.2)Body responsible for mediation procedures
VI.4.3)Review procedure
VI.4.4)Service from which information about the review procedure may be obtained
Ministry of Health of Republic of North Macedonia
Skopje
The former Yugoslav Republic of Macedonia
VI.5)Date of dispatch of this notice:
10/07/2019

Hyperlinks to Related Project Dossiers:

https://ted.europa.eu/udl?uri=TED:NOTICE:328428-2019:TEXT:EN:HTML&src=0